INFECT DRUG RESIST 潤(rùn)色咨詢

Infection and Drug Resistance

出版年份:暫無(wú)數(shù)據(jù) 年文章數(shù):2154 投稿命中率: 開(kāi)通期刊會(huì)員,數(shù)據(jù)隨心看

出版周期:Irregular 自引率:0.8% 審稿周期: 開(kāi)通期刊會(huì)員,數(shù)據(jù)隨心看

前往期刊查詢

投稿信息

投稿信息
審稿費(fèi)用
暫無(wú)數(shù)據(jù)
版面費(fèi)用
2766.67元/篇 (網(wǎng)友貢獻(xiàn),非官方數(shù)據(jù))
中國(guó)人發(fā)表比例
2023年中國(guó)人文章占該期刊總數(shù)量暫無(wú)數(shù)據(jù) (2022年為100.00%)
自引率
0.8 %
年文章數(shù)
2154
期刊官網(wǎng)
點(diǎn)擊查看 (點(diǎn)擊次數(shù):5547)
投稿鏈接
點(diǎn)擊查看 (點(diǎn)擊次數(shù):3413次)
作者需知
點(diǎn)擊查看 (點(diǎn)擊次數(shù):708次)
期刊簡(jiǎn)介
稿件收錄要求

Aims and Scope

Editor-in-Chief: Professor Suresh Antony

Infection and Drug Resistance is an international, peer-reviewed, open access journal that focuses on the optimal treatment of infection (bacterial, fungal and viral) and the development and institution of preventative strategies to minimize the development and spread of resistance..

The journal is specifically concerned with the epidemiology of antibiotic resistance and the mechanisms of resistance development and diffusion in both hospitals and the community. In particular, research and clinical development of novel mechanism of action anti-infectives and the optimal use of existing therapies will be highlighted. Other areas of coverage include diagnostic and early detection of infection, proteomic and genomic studies to characterize surface proteins in resistant organisms, and educational and infection control strategies. With increased mortality, morbidity and healthcare costs associated with developing resistance, research, clinical studies and programs designed to improve outcomes and patient adherence and satisfaction will be given priority.

The journal is characterized by the rapid reporting of reviews, guidelines, original research and clinical studies in all areas of infection and drug resistance.